Does BELUMOSUDIL Cause Neoplasm malignant? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Neoplasm malignant have been filed in association with BELUMOSUDIL (Rezurock). This represents 0.2% of all adverse event reports for BELUMOSUDIL.
6
Reports of Neoplasm malignant with BELUMOSUDIL
0.2%
of all BELUMOSUDIL reports
1
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From BELUMOSUDIL?
Of the 6 reports, 1 (16.7%) resulted in death, 2 (33.3%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELUMOSUDIL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BELUMOSUDIL Cause?
Inappropriate schedule of product administration (377)
Product use in unapproved indication (340)
Fatigue (246)
Nausea (154)
Product dose omission issue (143)
Drug ineffective (141)
Diarrhoea (136)
Death (135)
Condition aggravated (127)
Off label use (124)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which BELUMOSUDIL Alternatives Have Lower Neoplasm malignant Risk?
BELUMOSUDIL vs BELVIQ
BELUMOSUDIL vs BELZUTIFAN
BELUMOSUDIL vs BEMPEDOIC ACID
BELUMOSUDIL vs BEMPEDOIC ACID\EZETIMIBE
BELUMOSUDIL vs BEMPEGALDESLEUKIN